Pasar al contenido principal

MECANISMOS MOLECULARES E INMUNORREGULADORES MEDIADOS POR CONJUGADOS BIOACTIVOS EN ENFERMEDADES INFLAMATORIAS INTESTINALES

PID2023-147334OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF-ĸB signalling pathway

  • Leiva-Castro, Camila
  • Múnera-Rodríguez, Ana M.
  • Martínez-Bailén, Macarena
  • Carmona, Ana T.
  • López-Enríquez, Soledad
  • Palomares, Francisca
[Background and Purpose] Sulforaphane (SFN) has notable health benefits but faces challenges due to its poor solubility and delivery. This study investigates SFN-glycoconjugates effects on lipopolysaccharide (LPS)-induced inflammation in dendritic cells (DCs). With the aiming to enhance their therapeutic potential against inflammatory diseases. Novel monovalent SFN-glycoconjugates with mannose (Man) and fucose (0Fuc) were developed and tested for their anti-inflammatory and immune-modulatory properties in DCs from healthy donors under chronic LPS exposure., [Experimental Approach] By leveraging therapeutic strategies, SFN-glycoconjugates significantly improved the solubility and bioavailability of SFN, thereby overcoming the limitations of traditional delivery methods. Monocyte-derived DCs were treated with SFN-glycoconjugates and subsequently exposed to a chronic inflammatory environment induced by LPS., [Key Results] Our results showed that SFN-glycoconjugates enhance effectiveness in suppressing inflammation by targeting the p65 NF-κB pathway, without affecting MAPK signalling. SFN-glycoconjugates induce a tolerogenic immune response, characterized by increased IL-10 production and enhanced regulatory T- and B-cell proliferation. These effects surpass those of p65 NF-κB inhibition alone, highlighting a distinct and potent regulatory mechanism independent of MAPK pathways., [Conclusion and Implications] The integration of food therapeutic strategies not only enhances the stability and delivery of bioactive compounds but also broadens their potential applications in functional foods and therapeutic approaches. In particular, SFN-glycoconjugates represent a promising option as biologically active compounds for inflammatory diseases, offering enhanced anti-inflammatory and immunomodulatory effects through optimized delivery systems and the activation of specific molecular pathways., This work was supported by the Ministerio de Ciencia e Innovación (Grant PID2020-116460RB-100 funded by MCIN/AEI/10.13039/50110001103, Grant PID2023-147334OB-I00 funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by ‘ERDF A way of making Europe’, by ‘ERDF/EU’, by the ‘European Union’ and by Ramon y Cajal Program [RYC2021-031256-I] funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by ‘ESF Investing in your future’, by ‘ESF+’ or by ‘European Union NextGenerationEU/PRTR’), by the ‘VII Plan Propio de Investigación y Transferencia’ from the University of Seville (Project 202200000421 and Project 2023/00000482) and by Asociación Universitaria Iberoamericana de Postgrado scholarship for the Medical Research: Clinical and Experimental Master. We also thank CITIUS Universidad de Sevilla (MS and NMR services, including the flow cytometry services) and Edijs Jansons for technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions

  • Leiva-Castro, Camila
  • Múnera-Rodríguez, Ana M.
  • Torres-Joya, Gádor
  • Palomares-Jerez, Francisca
  • López-Enríquez, Soledad
Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint destruction. The gut microbiome has emerged as a key factor in the regulation of the immune system, and its dysbiosis has been implicated in the pathogenesis of rheumatoid arthritis. Nutraceuticals, including probiotics, omega-3 fatty acids, coenzyme Q10, vitamin D, and polyphenols, have shown potential in modulating the gut microbiota and inflammatory pathways. This review explores the interplay between nutraceuticals, gut microbiota, and immune function in rheumatoid arthritis, with attention to pharmacokinetics and safety. We discuss recent clinical evidence, elucidate molecular mechanisms of action, and highlight future research directions for integrating nutraceuticals into therapeutic strategies for rheumatoid arthritis., Funding for open access publishing: Universidad de Sevilla/CBUA. This work was supported by grants by “VII Plan Propio de Investigación y Transferencia” from the University of Seville (Project-2022/00000421 and Project-2023/00000482), and by the Ministerio de Ciencia e Innovación (grant PID2023-147334OB-I00 funded by MICIU/AEI/ https://doi.org/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by “ERDF/EU”, by the “European Union”, and by Ramon y Cajal program (RYC2021-031256–721 I) funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and, as appropriate, by “ESF Investing in your future”, by “ESF + ” or by “European Union NextGenerationEU/PRTR”), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Autophagy in Obesity and Type 2 Diabetes: Beyond the Protective Paradigm

  • Angarita-Plánchez, María Elena
  • Sánchez-Rodríguez, Paula
  • Múnera-Rodríguez, Ana M.
  • Leiva-Castro, Camila
  • Benítez-Márquez, Juan Manuel
  • Reina-Pérez, Icíar
  • Palomares, Francisca
  • López-Enríquez, Soledad
[Purpose of Review] This review examines the current evidence on autophagy dysregulation in obesity and type 2 diabetes mellitus (T2DM), with particular emphasis on its tissue-specific nature and implications for clinical translation., [Recent findings] Recent human and preclinical evidence indicates that autophagic alterations in metabolic disease are not uniformly suppressed but vary according to tissue type and disease stage. In adipose tissue, liver, skeletal muscle, pancreatic β cells, and immune cells, dysregulated mTORC1-AMPK signaling, defective mitophagy, and impaired lysosomal function contribute to insulin resistance, ectopic lipid accumulation, and metaflammation. However, most human studies rely on static markers such as LC3, p62, and Beclin-1, which do not reliably reflect dynamic autophagic flux. Recent advances, including organelle-specific biomarkers, ex vivo functional assays, and circulating exosomal cargo, offer new translational opportunities, although standardization remains limited., [Summary] Autophagy in metabolic disease represents a context-dependent maladaptation rather than a uniformly protective pathway. Future progress will depend on harmonized biomarker panels, functional assessment of autophagic flux in humans, and integration with metabolic phenotyping to enable precision-based therapeutic strategies., Funding for open access publishing: Universidad de Sevilla/CBUA. This work was supported by the Instituto de Salud Carlos III (ISCIII) (Grant PI25/00574), funded by MCIN/ISCIII/https://doi.org/10.13039/501100004587 and co-funded by the European Union, and by the Ministerio de Ciencia e Innovación (Grant PID2023-147334OB-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and, as appropriate, by ‘ERDF A way of making Europe’, by ‘ERDF/EU’, by the ‘European Union’, and by Ramon y Cajal program (RYC2021-031256-I) funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and, as appropriate, by ‘ESF Investing in your future’, by ‘ESF + ’ or by ‘European Union NextGenerationEU/PRTR’), and by the ‘VII Plan Propio de Investigación y Transferencia’ from the University of Seville (Project-2023/00000482 and Project-2024/00000357), Peer reviewed